• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

    4.425 +0.045 (+1.03%)
    Streaming Delayed Price Updated: 12:43 PM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,580,023
    Open 5.570
    Bid (Size) 4.420 (400)
    Ask (Size) 4.430 (900)
    Prev. Close 4.380
    Today's Range 4.410 - 5.710
    52wk Range 3.760 - 14.73
    Shares Outstanding 93,100,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why Myriad Genetics (MYGN) Stock Is Trading Up Today
    Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 4.9% in the morning session after the company reported better-than-expected fourth-quarter 2025 earnings that surpassed analyst... 
    Via StockStory
    Topics Government World Trade
    News headline image
    Six presented abstracts at ASCO-GU 2026 reinforce the clinical impact of Myriad’s Precise MRD, Prolaris, and MyRisk tests
    From Myriad Genetics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -27.9%
    -27.9%
    1 Month
    -23.8%
    -23.8%
    3 Month
    -42.8%
    -42.8%
    6 Month
    -24.9%
    -24.9%
    1 Year
    -67.9%
    -67.9%

    More News

    Read More
    News headline image
    Myriad Genetics (MYGN) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    Myriad Genetics Inc (NASDAQ:MYGN) Stock Surges 19.6% on Strong Q4 Earnings Beat ↗
    Via Chartmill
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    Myriad Genetics’s (NASDAQ:MYGN) Q4 CY2025 Sales Top Estimates, Stock Jumps 22%
    Via StockStory
    News headline image
    Myriad Genetics Reports Fourth Quarter and Full-Year 2025 Financial Results; Reiterates 2026 Financial Guidance Reflecting Strengthened Execution
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know
    Via StockStory
    Topics Government World Trade
    News headline image
    FirstGene Study Demonstrates High Analytical Sensitivity and Specificity for Each Component of the Test
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics to Release Fourth Quarter and Full Year 2025 Financial Results on February 23, 2026
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    3 Cash-Burning Stocks We Keep Off Our Radar
    Via StockStory
    Topics Bankruptcy
    News headline image
    1 Small-Cap Stock on Our Watchlist and 2 That Underwhelm
    Via StockStory
    News headline image
    Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm
    Via StockStory
    Topics Economy Stocks
    News headline image
    Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    3 Stocks Under $10 We Think Twice About
    Via StockStory
    News headline image
    3 Unprofitable Stocks That Fall Short
    Via StockStory
    News headline image
    Myriad Genetics (MYGN) Stock Trades Up, Here Is Why
    Via StockStory
    News headline image
    Why Myriad Genetics (MYGN) Stock Is Up Today
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    News headline image
    Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings?
    Via StockStory
    Topics Stocks
    News headline image
    1 Healthcare Stock with Promising Prospects and 2 We Question
    Via StockStory
    Topics Economy Stocks
    News headline image
    Why Myriad Genetics (MYGN) Stock Is Trading Lower Today
    Via StockStory
    Topics Government
    News headline image
    Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
    From Myriad Genetics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Myriad Genetics, Inc. - Common Stock publicly traded?
    Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
    What exchange does Myriad Genetics, Inc. - Common Stock trade on?
    Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
    The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
    What is the current price of Myriad Genetics, Inc. - Common Stock?
    The current price of Myriad Genetics, Inc. - Common Stock is 4.425
    When was Myriad Genetics, Inc. - Common Stock last traded?
    The last trade of Myriad Genetics, Inc. - Common Stock was at 02/24/26 12:43 PM ET
    What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
    The market capitalization of Myriad Genetics, Inc. - Common Stock is 411.97M
    How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
    Myriad Genetics, Inc. - Common Stock has 412M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.